Lebrun Labs LLC

Lebrun Labs LLC, a self-certified small disadvantaged business and sole proprietorship based in Anaheim, California, operates as a prime recipient of federal research grants focused on developing non-animal alternative testing methods for chemical hazard assessment and mitigation. The company is structured as a for-profit limited liability company and is registered as a manufacturer of goods.

Lebrun Labs has built its federal footprint exclusively in the life-sciences and chemical-safety research space through four federal grants awarded by the National Institute of Environmental Health Sciences (NIEHS) and the National Institutes of Health Office of the Director between 2023 and 2026. The company's core capability portfolio centers on developing in vitro diagnostic kits and testing protocols to replace animal testing for ocular irritation and dermal corrosion assessment, addressing regulatory bans on animal testing in California, the United States, and the European Union. Representative work includes a Phase II NIEHS grant awarded May 10, 2023 (completion April 30, 2026) for the In Vitro Depth of Injury Eye Irritation Test (IVD EIT), a nonanimal kit and service for detecting and classifying ocular irritants across all severity levels; an NIEHS grant awarded June 22, 2026 (completion April 30, 2028) to further develop the IVD EIT methodology; an April 15, 2024 NIEHS award (completion March 31, 2027) for an in chemico field and laboratory test to identify dermal corrosives using cell-free, shelf-stable test chemistry and portable spectrophotometric measurement; and a July 1, 2023 NIH Office of the Director grant (completion June 30, 2025) to develop antioxidant eye wash formulations to counter ocular chemical threats listed by the Department of Homeland Security.

Customer concentration is entirely within the Department of Health and Human Services: six awards flow to NIEHS, one to HHS broadly, and one to the NIH Office of the Director. The company operates exclusively as a prime recipient and holds no subcontractor positions. Two awards reach ultimate completion within the next twenty-four months, creating near-term recompete opportunity. Combined federal dollars obligated across all eight awards totals $11.2 million, with award activity showing irregular annual timing (three awards in 2015, one in 2020, two in 2023, one in 2024, and one in 2026).